Vifor Pharma and Akebia to sell Vadadustat to Fresenius Medical Care

Vifor Pharma Group and Akebia Therapeutics have entered an exclusive licence agreement to sell Vadadustat to Fresenius Medical Care dialysis clinics located in the US after securing approval from the US Food and Drug Administration (FDA).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news